2328
S. Sasaki et al. / Tetrahedron Letters 51 (2010) 2326–2328
Table 5
Supplementary data
Enantioselective F–C alkylation of 1 with 6a–l
Experimental procedures, structural proofs, NMR spectra, HPLC
profiles, and X-ray crystallography data are available. CCDC
730908 contains the supplementary crystallographic data for this
paper. These data can be obtained free of charge from The Cam-
Entry
R
Reaction time
Yielda (%)
eeb (%)
References and notes
1
2
3
4
5
6
7
8
9
o-MeO–Ph (6a)
m-MeO–Ph (6b)
p-MeO–Ph (6c)
o-Me–Ph (6d)
m-Me–Ph (6e)
p-Me–Ph (6f)
p-F–Ph (6g)
o-Cl–Ph (6h)
m-Cl–Ph (6i)
p-Cl–Ph (6j)
4 d
4 d
4 d
3 d
3 d
3 d
22 h
22 h
22 h
22 h
22 h
36 h
98 (7a)
96 (7b)
78 (7c)
90 (7d)
95 (7e)
95 (7f)
93 (7g)
99 (7h)
99 (7i)
94 (7j)
99 (7k)
95 (7l)
72
84
71
81
84
81
79
81
83
80
86
17
1. (a)Organofluorine Compounds in Medicinal and Biomedical Applications; Filler, R.,
Kobayashi, Y., Yagupolskii, L. M., Eds.; Elsevier: Amsterdam, 1993;
(b)Organofluorine Chemistry; Principles and Commercial Applications; Banks, R.
E., Smart, B. E., Tatlow, J. C., Eds.; Plenum Press: New York, 1994; (c)Biomedical
Frontiers of Fluorine Chemistry; Ojima, I., McCarthy, J. R., Welch, J. T., Eds.; ACS
Editions: Washington, DC, 1996.
2. (a)Organofluorine Chemistry; Uneyama, K., Ed.; Blackwell Publishing: Oxford,
2006; (b) Kitazume, T.; Matsuda, T.; Nakamura, K. Adv. Org. Synth. 2006, 2, 463–
490; (c) Kumadaki, I. Yakugaku Zasshi 2006, 126, 1059–1085; (d) Santos, F.;
Sanz-Cervera, J. F.; Aceña, J. L.; Sánchez-Roselló, M. Synlett 2009, 4, 525–549.
3. (a) Linderman, J. R.; Jamois, A. E.; Tennyson, D. S. J. Org. Chem. 1994, 59, 957–
962; (b) Andrew, R. J.; Mellor, J. M. Tetrahedron 2000, 56, 7261–7266; (c)
Nenajdenko, V. G.; Smolko, K. I.; Balenkova, E. S. Tetrahedron: Asymmetry 2001,
12, 1259–1266; (d) Kawano, Y.; Kaneko, N.; Mukaiyama, T. Bull. Chem. Soc. Jpn.
2006, 79, 1133–1145; (e) Zhang, D.; Yuan, C. Eur. J. Org. Chem. 2007, 23, 3916–
3924.
10
11
12
p-Br–Ph (6k)
n-C6H13 (6l)
a
Isolated yield.
Determined by HPLC.
b
4. For selected examples, see: (a) Jørgensen, K. A. Synthesis 2003, 1117–1125; (b)
Bandini, M.; Melloni, A.; Umani-Ronchi, A. Angew. Chem., Int. Ed. 2004, 43, 550–
556; (c) Bartoli, G.; Bosco, M.; Carlone, A.; Pesciaioli, F.; Sambri, L.; Melchiorre, P.
Org. Lett. 2007, 9, 1403–1405; (d) Kang, Q.; Zhao, Z.-A.; You, S.-L. J. Am. Chem. Soc.
2007, 129, 1484–1485; (e) Blay, G.; Fernández, I.; Pedro, J. R.; Vila, C. Org. Lett.
2007, 9, 2601–2604; (f) Zhang, G.-W.; Wang, L.; Nie, J.; Ma, J.-A. Adv. Synth. Catal.
2008, 350, 1457–1463; (g) Nakamura, S.; Hyodo, K.; Nakamura, Y.; Shibata, N.;
Toru, T. Adv. Synth. Catal. 2008, 350, 1443–1448; (h) Poulsen, T. B.; Jørgensen, K.
A. Chem. Rev. 2008, 108, 2903–2915; (i) Cai, Q.; Zhao, Z.-A.; You, S.-L. Angew.
Chem., Int. Ed. 2009, 48, 7428–7431; (j) Ghandi, M.; Taheri, A. Molecules 2009, 14,
1056–1061; (k) Suyama, K.; Matsumoto, K.; Katsuki, T. Heterocycles 2009, 77,
817–824; (l) Gao, Y.-H.; Yang, L.; Zhou, W.; Xu, L.-W.; Xia, C.-G. Appl. Organomet.
Chem. 2009, 23, 114–118; (m) Liu, Y.; Shang, D.; Zhou, X.; Liu, X.; Feng, X. Chem.
Eur. J. 2009, 15, 2055–2058; (n) Kang, Q.; Zhao, Z.-A.; You, S.-L. Tetrahedron 2009,
65, 1603–1607; (o) Liu, Y.-H.; Liu, Q.-S.; Zhang, Z.-H. Tetrahedron Lett. 2009, 50,
916–921; (p) You, S.-L.; Cai, Q.; Zeng, M. Chem. Soc. Rev. 2009, 38, 2190–2201.
5. For selected examples, see: (a) Schaus, S. E.; Jacobsen, E. N. Org. Lett. 2000, 2,
1001–1004; (b) Evans, D. A.; Scheidt, K. A.; Fandrick, K. R.; Lam, H. W.; Wu, J. J.
Am. Chem. Soc. 2003, 125, 10780–10781; (c) Evans, D. A.; Fandrick, K. R.; Song,
H.-J. J. Am. Chem. Soc. 2005, 127, 8942–8943; (d) Aspinall, H. C.; Bickley, J. F.;
Greeves, N.; Kelly, R. V.; Smith, P. M. Organometallics 2005, 24, 3458–3467; (e)
Kikuchi, S.; Sato, H.; Fukuzawa, S. Synlett 2006, 7, 1026; (f) Evans, D. A.; Fandrick,
K. R.; Song, H.-J.; Scheidt, K. A.; Xu, R. J. Am. Chem. Soc. 2007, 129, 10029–10041;
(g) Desimoni, G.; Faita, G.; Toscanini, M.; Boiocchi, M. Chem. Eur. J. 2007, 13,
9478–9485; (h) Comelles, J.; Pericas, A.; Moreno-Manas, M.; Vallribera, A.;
Drudis-Sole, G.; Lledos, A.; Parella, T.; Roglans, A.; Garcia-Granda, S.; Roces-
Fernandez, L. J. Org. Chem. 2007, 72, 2228–2231; (i) Lu, G.; Morimoto, H.;
Matsunaga, S.; Shibasaki, M. Angew. Chem., Int. Ed. 2008, 47, 6847–6850.
6. (a) Desimoni, G.; Faita, G.; Guala, M.; Laurenti, A.; Pratelli, C. J. Org. Chem. 2003,
68, 7862–7866; (b) Desimoni, G.; Faita, G.; Guala, M.; Laurenti, A. Eur. J. Org.
Chem. 2004, 3057–3062.
Scheme 1. Determination of absolute configuration of 7k and 3a.
and our simple procedure is particularly suitable for introducing a
trifluoromethyl ketone unit into drug candidates having complex
structures.
7. Desimoni, G.; Faita, G.; Guala, M.; Laurenti, A.; Mella, M. Chem. Eur. J. 2005, 11,
3816–3824.
8. The reaction was performed with 2.5 mol % Dy(OTf)3 and 5 mol % i-Pr-Pybox to
give product 3a in low yield and poor enantioselectivity (22%, 42%ee). Though
5 mol % dried Dy(OTf)3 (60 °C, 30 min, under vacuum) was used, the F–C
alkylation did not proceed. Therefore for providing the optimum condition we
should use a little excess Dy(OTf)3 (7.5 mol %) and 5 mol % of i-Pr-Pybox without
purification.
Acknowledgment
This work was supported in part by the Open Research Center
Project.